The Neuralink device is designed to be surgically implanted and, according to CEO Elon Musk, will eventually be marketed to the general public.
News Join us on social networks
Elon Musk’s brain-computer interface (BCI) startup, Neuralink, reportedly received approval from the United States Food and Drug Administration (FDA) to conduct some form of “in-human” trials for its surgically implanted brain device.
Congratulations Neuralink team! https://t.co/AWZGf33UDr
— Elon Musk (@elonmusk) May 26, 2023
It’s unclear at this time what kind of trials the Neuralink tweet is referring to — the only other information mentioned was that the company isn’t accepting applicants yet.
Neuralink was denied the FDA’s approval for human trials in early 2022 over several concerns related to safety, which, at the time, the company was
Join the conversation!
Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!